We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Process Validation Should Take Lifecycle Approach, European Commission Says
Process Validation Should Take Lifecycle Approach, European Commission Says
Drugmakers should clearly define their validation activities in a validation master plan that accounts for the lifecycle of a product and related plant equipment, the European Commission says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor